Literature DB >> 19693093

Biallelic inactivation of TRAF3 in a subset of B-cell lymphomas with interstitial del(14)(q24.1q32.33).

I Nagel, S Bug, H Tönnies, O Ammerpohl, J Richter, I Vater, E Callet-Bauchu, M J Calasanz, J A Martinez-Climent, C Bastard, M Salido, E Schroers, J I Martin-Subero, S Gesk, L Harder, A Majid, M J S Dyer, R Siebert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19693093     DOI： 10.1038/leu.2009.149

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  26 in total

1.  A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma.

Authors:  Itziar Salaverria; Idoia Martin-Guerrero; Rabea Wagener; Markus Kreuz; Christian W Kohler; Julia Richter; Barbara Pienkowska-Grela; Patrick Adam; Birgit Burkhardt; Alexander Claviez; Christine Damm-Welk; Hans G Drexler; Michael Hummel; Elaine S Jaffe; Ralf Küppers; Christine Lefebvre; Jasmin Lisfeld; Markus Löffler; Roderick A F Macleod; Inga Nagel; Ilske Oschlies; Maciej Rosolowski; Robert B Russell; Grzegorz Rymkiewicz; Detlev Schindler; Matthias Schlesner; René Scholtysik; Carsten Schwaenen; Rainer Spang; Monika Szczepanowski; Lorenz Trümper; Inga Vater; Swen Wessendorf; Wolfram Klapper; Reiner Siebert
Journal:  Blood       Date:  2014-01-07       Impact factor: 22.113

2.  Nuclear TRAF3 is a negative regulator of CREB in B cells.

Authors:  Nurbek Mambetsariev; Wai W Lin; Laura L Stunz; Brett M Hanson; Joanne M Hildebrand; Gail A Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-11       Impact factor: 11.205

3.  Expression and function of a novel isoform of Sox5 in malignant B cells.

Authors:  Shanique K E Edwards; Anand Desai; Yan Liu; Carissa R Moore; Ping Xie
Journal:  Leuk Res       Date:  2013-12-25       Impact factor: 3.156

4.  Specific deletion of TRAF3 in B lymphocytes leads to B-lymphoma development in mice.

Authors:  C R Moore; Y Liu; C Shao; L R Covey; H C Morse; P Xie
Journal:  Leukemia       Date:  2011-10-28       Impact factor: 11.528

5.  The oncogenic membrane protein LMP1 sequesters TRAF3 in B-cell lymphoma cells to produce functional TRAF3 deficiency.

Authors:  Pradeep Bangalore-Prakash; Laura L Stunz; Nurbek Mambetsariev; Amy L Whillock; Bruce S Hostager; Gail A Bishop
Journal:  Blood Adv       Date:  2017-12-18

6.  Myeloid cell TRAF3 regulates immune responses and inhibits inflammation and tumor development in mice.

Authors:  Almin I Lalani; Carissa R Moore; Chang Luo; Benjamin Z Kreider; Yan Liu; Herbert C Morse; Ping Xie
Journal:  J Immunol       Date:  2014-11-24       Impact factor: 5.422

Review 7.  Targeting signaling factors for degradation, an emerging mechanism for TRAF functions.

Authors:  Xiao-Dong Yang; Shao-Cong Sun
Journal:  Immunol Rev       Date:  2015-07       Impact factor: 12.988

Review 8.  Roles for TNF-receptor associated factor 3 (TRAF3) in lymphocyte functions.

Authors:  Zuoan Yi; Wai Wai Lin; Laura L Stunz; Gail A Bishop
Journal:  Cytokine Growth Factor Rev       Date:  2013-12-25       Impact factor: 7.638

9.  Signaling mechanisms of bortezomib in TRAF3-deficient mouse B lymphoma and human multiple myeloma cells.

Authors:  Shanique K E Edwards; Yeming Han; Yingying Liu; Benjamin Z Kreider; Yan Liu; Sukhdeep Grewal; Anand Desai; Jacqueline Baron; Carissa R Moore; Chang Luo; Ping Xie
Journal:  Leuk Res       Date:  2015-12-19       Impact factor: 3.156

10.  Elevated Choline Kinase α-Mediated Choline Metabolism Supports the Prolonged Survival of TRAF3-Deficient B Lymphocytes.

Authors:  Samantha Gokhale; Wenyun Lu; Sining Zhu; Yingying Liu; Ronald P Hart; Joshua D Rabinowitz; Ping Xie
Journal:  J Immunol       Date:  2019-12-11       Impact factor: 5.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.